Beth Odeh-Frikert is the Head of Global Alliance and Asset Management in Corporate Business Development at Genentech. During her 25-year career at Roche and Genentech, Beth has held key leadership positions across all phases of drug development and commercialization. Through her career, she has led global teams within Partnering, Product Development, Medical, Commercial and Manufacturing organizations. Beth received her Doctorate of Pharmacy degree from the University of Michigan and completed a 2-year post-doctoral fellowship at Roche and Genentech, followed by an executive business program through INSEAD. In her current role, Beth leads with a passion for science and a commitment to bring innovative medicines to patients through partnerships.